Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.

[1]  Philip J Rosenfeld,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[2]  Kazuhisa Takahashi,et al.  Endostatin gene transfer in murine lung carcinoma cells induces vascular endothelial growth factor secretion resulting in up-regulation of in vivo tumorigenecity. , 2006, Cancer letters.

[3]  O. Sürücü,et al.  Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. , 2005, Cancer research.

[4]  D. Largaespada,et al.  Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  L. Holmgren,et al.  Angiomotin Regulates Endothelial Cell-Cell Junctions and Cell Motility* , 2005, Journal of Biological Chemistry.

[6]  S. Pizzo,et al.  Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated , 2005, Journal of cellular biochemistry.

[7]  C. Bokemeyer,et al.  Antiangiogenic treatment with endostatin inhibits progression of AML in vivo , 2005, Leukemia.

[8]  S. Ramakrishnan,et al.  Addition of an aminopeptidase N‐binding sequence to human endostatin improves inhibition of ovarian carcinoma growth , 2005, Cancer.

[9]  R. Motzer,et al.  Phase 2 trials of SU11248 show antitumor activity in second-line therapy for patients with metastatic renal cell carcinoma (RCC) , 2005 .

[10]  Jiyan Liu,et al.  Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine , 2005, Anti-cancer drugs.

[11]  Xingzhi Song,et al.  Results of phase III trial of rh-endostatin (YH-16) in advanced non-small cell lung cancer (NSCLC) patients , 2005 .

[12]  J. Folkman,et al.  A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. , 2005, Cancer research.

[13]  W. Jia,et al.  Oncolytic herpesvirus with secretable angiostatic proteins in the treatment of human lung cancer cells. , 2005, Anticancer research.

[14]  D. Schuppan,et al.  Combined endostatin/sFlt‐1 antiangiogenic gene therapy is highly effective in a rat model of HCC , 2005, Hepatology.

[15]  D. Mukhopadhyay,et al.  Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. , 2005, Cancer cell.

[16]  N. Miyake,et al.  Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl , 2005, Gene Therapy.

[17]  R. Kalluri,et al.  Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Sham,et al.  Potent antitumor efficacy of an E1B 55kDa‐deficient adenovirus carrying murine endostatin in hepatocellular carcinoma , 2005, International journal of cancer.

[19]  I. B. Borel Rinkes,et al.  Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells , 2005, British Journal of Cancer.

[20]  Yayi Hou,et al.  Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer , 2005, Cancer Gene Therapy.

[21]  D. Sørensen,et al.  Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. , 2005, Blood.

[22]  F. Paraf,et al.  Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  P. Black,et al.  Therapy of hematogenous melanoma brain metastases with endostatin. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  L. Hlatky,et al.  Endostatin: the logic of antiangiogenic therapy. , 2005, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[25]  C. Ren,et al.  Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[27]  R. Timpl,et al.  The Minimal Active Domain of Endostatin Is a Heparin-Binding Motif that Mediates Inhibition of Tumor Vascularization , 2004, Cancer Research.

[28]  Wenlin Huang,et al.  Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein. , 2004, Chinese medical journal.

[29]  Xia Zhao,et al.  [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus]. , 2004, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[30]  A. Shiau,et al.  Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models , 2004, The journal of gene medicine.

[31]  R. Tanaka,et al.  Gene therapy of brain tumor with endostatin. , 2004, Drugs of today.

[32]  T. Misawa,et al.  Adeno-Associated Viral Vector-Mediated Expression of Endostatin Inhibits Tumor Growth and Metastasis in an Orthotropic Pancreatic Cancer Model in Hamsters , 2004, Cancer Research.

[33]  T. Tomonaga,et al.  Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation , 2004, Cancer Gene Therapy.

[34]  S. Indraccolo,et al.  Undermining tumor angiogenesis by gene therapy: an emerging field. , 2004, Current gene therapy.

[35]  T. Pawlik,et al.  Oncolysis by viral replication and inhibition of angiogenesis by a replication‐conditional herpes simplex virus that expresses mouse endostatin , 2004, Cancer.

[36]  T. Wagner,et al.  Intra-arterial delivery of endostatin gene to brain tumors prolongs survival and alters tumor vessel ultrastructure , 2004, Gene Therapy.

[37]  J. Folkman.  Endogenous angiogenesis inhibitors , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[38]  Yanan Sun,et al.  [Endostatin in the treatment of the transplantable model of human laryngeal squamous carcinoma in nude mice]. , 2004, Zhonghua er bi yan hou ke za zhi.

[39]  Jin-song Hou,et al.  [The inhibitory effect of human endostatin gene on tumor growth of tongue squamous cell carcinoma]. , 2004, Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

[40]  Wenlin Huang,et al.  Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. , 2004, World journal of gastroenterology.

[41]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[42]  J. Sham,et al.  [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin]. , 2004, Zhonghua yi xue za zhi.

[43]  Robert S. Kerbel,et al.  The anti-angiogenic basis of metronomic chemotherapy , 2004, Nature Reviews Cancer.

[44]  Min Zhang,et al.  Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. , 2004, World journal of gastroenterology.

[45]  K. Alitalo,et al.  An Endostatin-derived Peptide Interacts with Integrins and Regulates Actin Cytoskeleton and Migration of Endothelial Cells* , 2004, Journal of Biological Chemistry.

[46]  H. Sasaki,et al.  Endostatin gene transfection using a cationic lipid: advantages of transfection before tumor cell inoculation and repeated transfection , 2004, Cancer Gene Therapy.

[47]  Linhong Li,et al.  Rapid, in vivo, evaluation of antiangiogenic and antineoplastic gene products by nonviral transfection of tumor cells , 2004, Cancer Gene Therapy.

[48]  K. Moulton,et al.  E-selectin is required for the antiangiogenic activity of endostatin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Choi,et al.  Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model. , 2004, World journal of gastroenterology.

[50]  D. Gridley,et al.  Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model. , 2004, International journal of radiation oncology, biology, physics.

[51]  J. Debus,et al.  Endostatin's antiangiogenic signaling network. , 2004, Molecular cell.

[52]  C. Cordon-Cardo,et al.  Inhibition of Orthotopic Human Bladder Tumor Growth by Lentiviral Gene Transfer of Endostatin , 2004, Clinical Cancer Research.

[53]  J. Davies,et al.  Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 , 2004, Nature Medicine.

[54]  W. Grizzle,et al.  Adeno-Associated Virus 2-Mediated Antiangiogenic Cancer Gene Therapy , 2004, Cancer Research.

[55]  R. Carroll,et al.  Antiangiogenic Therapy by Local Intracerebral Microinfusion Improves Treatment Efficiency and Survival in an Orthotopic Human Glioblastoma Model , 2004, Clinical Cancer Research.

[56]  Philip Hahnfeldt,et al.  Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects. , 2003, Cancer research.

[57]  Z. Du,et al.  The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism. , 2003, The Journal of urology.

[58]  S. Donnini,et al.  Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[59]  E. Mark,et al.  Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline. , 2003, Chest.

[60]  P. Bornstein,et al.  Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline. , 2003, Biochemical and biophysical research communications.

[61]  M. Hofmann,et al.  Low dose carboplatin combined with angiostatic agents prevents metastasis in human testicular germ cell tumor xenografts. , 2003, The Journal of urology.

[62]  S. Kaneko,et al.  Continuous versus intermittent administration of human endostatin in xenografted human neuroblastoma. , 2003, Journal of pediatric surgery.

[63]  A. Fortier,et al.  Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  Qiang Liu,et al.  Retroviral endostatin gene transfer inhibits human colon cancer cell growth in vivo. , 2003, Chinese medical journal.

[65]  Wenlin Huang,et al.  [Inhibitive effects of recombinant adenovirus-mediated human endostatin on the growth of human hepatocellular carcinoma xenograft in nude mice]. , 2003, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[66]  M. Cattaneo,et al.  Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. , 2003, Journal of medicinal chemistry.

[67]  H. Uehara.  Angiogenesis of prostate cancer and antiangiogenic therapy. , 2003, The journal of medical investigation : JMI.

[68]  B. Sipos,et al.  Retroviral endostatin gene transfer inhibits growth of human lung cancer in a murine orthotopic xenotransplant model , 2003, Langenbeck's Archives of Surgery.

[69]  S. Sakiyama,et al.  Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene. , 2003, International journal of oncology.

[70]  M. T. Beck,et al.  Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer. , 2003, Cancer research.

[71]  T. Salo,et al.  Endostatin Inhibits Human Tongue Carcinoma Cell Invasion and Intravasation and Blocks the Activation of Matrix Metalloprotease-2, -9, and -13* , 2003, Journal of Biological Chemistry.

[72]  F. Robertson,et al.  AIDS‐related Kaposi's sarcoma cells rapidly internalize endostatin, which co‐localizes to tropomysin microfilaments and inhibits cytokine‐mediated migration and invasion , 2003, Journal of cellular biochemistry.

[73]  Ding‐Shinn Chen,et al.  Concurrent delivery of GM‐CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors , 2003, The journal of gene medicine.

[74]  Raghu Kalluri,et al.  Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Folkman,et al.  Treatment of Human Pancreatic Cancer in Mice with Angiogenic Inhibitors , 2003, World Journal of Surgery.

[76]  F. Robertson,et al.  Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. , 2003, Anticancer research.

[77]  M. Cattaneo,et al.  Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. , 2003, Experimental cell research.

[78]  Xiu-ying Li,et al.  [Effect of transfection of hEndostatin gene on CNE2 cell xenograft growth in nude mice]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.

[79]  R. Kauppinen,et al.  The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice , 2002, Cancer Gene Therapy.

[80]  Susan M. Kilroy,et al.  PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. , 2002, The Journal of clinical investigation.

[81]  I. B. Borel Rinkes,et al.  Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model , 2002, The British journal of surgery.

[82]  K. Alitalo,et al.  Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. , 2002, Cancer research.

[83]  A. Feldman,et al.  Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin , 2002, International journal of cancer.

[84]  J. Wallace,et al.  Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  L. Devy,et al.  Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid , 2002, Journal of Pharmacology and Experimental Therapeutics.

[86]  Xuan Wang,et al.  [Inhibitory effect of endostatin mediated by retroviral gene transfer on human liver carcinoma SMMC7721 in vivo]. , 2002, Zhonghua wai ke za zhi [Chinese journal of surgery].

[87]  S. Szala,et al.  Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread , 2002, Cancer Gene Therapy.

[88]  N. Muzyczka,et al.  Adeno-associated virus–mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo , 2002, Cancer Gene Therapy.

[89]  F. Steele.  Can "negative" be positive? , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[90]  C. Eaves,et al.  Unfulfilled promise of endostatin in a gene therapy-xenotransplant model of human acute lymphocytic leukemia. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[91]  Yihai Cao,et al.  Continuous intravascular secretion of endostatin in mice from transduced hematopoietic stem cells. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[92]  E. Marshall.  Setbacks for Endostatin , 2002, Science.

[93]  D. Sørensen,et al.  Inhibitors of angiogenesis selectively reduce the malignant cell load in rodent models of human myeloid leukemias , 2002, Leukemia.

[94]  I. Peroulis,et al.  Antiangiogenic activity of endostatin inhibits c6 glioma growth , 2002, International journal of cancer.

[95]  R. Bookstein,et al.  Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo , 2001, Cancer Gene Therapy.

[96]  M. Neumaier,et al.  Human endostatin inhibits growth of human non‐small‐cell lung cancer in a murine xenotransplant model , 2001, International journal of cancer.

[97]  M. Passos-Bueno,et al.  High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours , 2001, European Journal of Human Genetics.

[98]  E. Gorelik,et al.  Immune Response Against 3LL Lewis Lung Carcinoma Potentiates the Therapeutic Efficacy of Endostatin , 2001, Journal of immunotherapy.

[99]  R. D'Amato,et al.  Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. , 2001, Cancer research.

[100]  H. Fine,et al.  Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites. , 2001, Human gene therapy.

[101]  A. Nienhuis,et al.  Autocrine expression of both endostatin and green fluorescent protein provides a synergistic antitumor effect in a murine neuroblastoma model , 2001, Cancer Gene Therapy.

[102]  Z Chen,et al.  Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[103]  M. Shichiri,et al.  Antiangiogenesis signals by endostatin. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[104]  R. D'Amato,et al.  Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[105]  S. Szala,et al.  Intra‐tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth , 2001, International journal of cancer.

[106]  J. Folkman,et al.  Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice. , 2001, Journal of the National Cancer Institute.

[107]  G. Nolan,et al.  Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[108]  G. Asano,et al.  Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. , 2000, The Journal of rheumatology.

[109]  C. Schnell,et al.  Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin. , 2000, Human gene therapy.

[110]  G. Pruneri,et al.  Endostatin, an antiangiogenic drug, induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma. , 2000, Blood.

[111]  A. Eggert,et al.  High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[112]  S. Woo,et al.  Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. Folkman,et al.  Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. , 2000, Cancer research.

[114]  J. Folkman,et al.  Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. , 2000, Cancer research.

[115]  A. Feldman,et al.  Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. , 2000, Cancer research.

[116]  H. Ploegh,et al.  Secreted cathepsin L generates endostatin from collagen XVIII , 2000, The EMBO journal.

[117]  K. Seibert,et al.  Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. , 2000, Cancer research.

[118]  J. Folkman,et al.  The generation of endostatin is mediated by elastase. , 1999, Cancer research.

[119]  I Que,et al.  Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding , 1999, The EMBO journal.

[120]  J. Mulliken,et al.  Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a , 1999, Pediatrics.

[121]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[122]  J. Shiloach,et al.  Zinc-binding of endostatin is essential for its antiangiogenic activity. , 1998, Biochemical and biophysical research communications.

[123]  C. Ezzell.  Starving tumors of their lifeblood. , 1998, Scientific American.

[124]  R. Timpl,et al.  Zinc-dependent dimers observed in crystals of human endostatin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[125]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[126]  S. Fox,et al.  Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes , 1997, Cancer research.

[127]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[128]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[129]  A. Ooshima,et al.  Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-Xaa-Yaa repeats identify a distinct family of collagenous proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[130]  Peter J. Polverini,et al.  Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene , 1989, Cell.

[131]  Z. Hui,et al.  Inhibitory effect of recombinant endostatin on angiogenesis and tumor growth of hepatoma , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[132]  S. Ramakrishnan,et al.  Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice , 2005, Gene Therapy.

[133]  G. Yin,et al.  Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models , 2004, Angiogenesis.

[134]  Y. M. Lee,et al.  N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent. , 2004, Oncology reports.

[135]  A. Fortier,et al.  Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile , 2004, Angiogenesis.

[136]  I. Treilleux,et al.  Lack of Antitumor Activity of Recombinant Endostatin in a Human Neuroblastoma Xenograft Model , 2004, Journal of Neuro-Oncology.

[137]  H. Sasaki,et al.  Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery , 2003, Gene Therapy.

[138]  Ying-fang Fan,et al.  [Inhibitory effect of recombinant human endostatin on angiogenesis and lung metastasis of mouse lung adenocarcinoma LA795]. , 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[139]  Wenlin Huang,et al.  [Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.

[140]  Giovanni Martinelli,et al.  Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[141]  N. Muzyczka,et al.  Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[142]  Rolf Bjerkvig,et al.  Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma. , 2002, Neuro-oncology.

[143]  Anthony Atala,et al.  Continuous release of endostatin from microencapsulated engineered cells for tumor therapy , 2001, Nature Biotechnology.

[144]  E. Scanziani,et al.  Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice , 2001, Gene Therapy.

[145]  E. Gorelik,et al.  Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect. , 2001, Cancer research.

[146]  P. Okunieff,et al.  Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. , 2001, Cancer research.

[147]  R. Xiu,et al.  Anticancer treatment of endostatin gene therapy by targeting tumor neovasculature in C57/BL mice. , 2000, Clinical hemorheology and microcirculation.

[148]  V. Sukhatme,et al.  Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. , 1999, Cancer research.

[149]  William Arbuthnot Sir Lane,et al.  Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth. , 1994, Cold Spring Harbor symposia on quantitative biology.

[150]  R. Kalluri,et al.  Cited Articles Citing Articles E-mail Alerts Endogenous Inhibitors of Angiogenesis , 2022 .